77 results on '"Gomez-Pinedo U"'
Search Results
2. Modelos experimentales murinos en la esclerosis lateral amiotrófica. Puesta al día
3. Cell therapy as a treatment strategy in amyotrophic lateral sclerosis
4. Exonic variants of the P2RX7 gene in familial multiple sclerosis
5. Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
6. NG2 and GFAP co-expression after differentiation in cells transfected with mutant GFAP and in undifferentiated glioma cells
7. Coexpresión de NG2/GFAP tras la diferenciación en células transfectadas con las mutaciones de GFAP y en células procedentes de gliomas indiferenciados
8. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
9. Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease
10. ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
11. La eritropoyetina humana recombinante reduce la disfunción sensoriomotora y el deterioro cognitivo en ratas con enfermedad renal crónica
12. Experimental models of demyelination and remyelination
13. Modelos experimentales de desmielinización-remielinización
14. Neuroprotective effects of phytochemicals on dopaminergic neuron cultures
15. Efecto neuroprotector de fitoquímicos en cultivo de neuronas dopaminérgicas
16. Myelin changes in Alexander disease
17. La alteración de la mielina en la enfermedad de Alexander
18. Histological changes in the rat brain and spinal cord following prolonged intracerebroventricular infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients are similar to those caused by the disease
19. La infusión intracerebroventricular prolongada de líquido cefalorraquídeo procedente de pacientes con esclerosis lateral amiotrófica provoca cambios histológicos en el cerebro y la médula espinal de la rata similares a los hallados en la enfermedad
20. Vitamin D and remyelination in multiple sclerosis
21. Vitamina D y remielinización en la esclerosis múltiple
22. Astrocytes in neurodegenerative diseases (I): function and molecular description
23. Astrocitos en las enfermedades neurodegenerativas (I): función y caracterización molecular
24. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis
25. Cambios celulares producidos por la citotoxicidad del líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica sobre cultivos de neuronas motoras
26. Biomaterial- and stem cell–based treatment strategies for diseases of the central nervous system
27. Molecular aspects of hepatic encephalopathy
28. Aspectos moleculares de la encefalopatía hepática
29. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
30. Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats
31. The Adult Macaque Spinal Cord Central Canal Zone Contains Proliferative Cells and Closely Resembles the Human
32. Terapia celular en la esclerosis lateral amiotrófica: ciencia y controversia
33. Ultrastructural analysis of guided nerve regeneration using progesterone‐ and pregnenolone‐loaded chitosan prostheses
34. Beneficial effects of α-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain
35. Cell therapy in amyotrophic lateral sclerosis: science and controversy
36. Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice
37. Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy.
38. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1 G93A mice by reducing inflammatory pathways in the adipose tissue.
39. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities.
40. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome.
41. Editorial: Current advances in genetic presentations of dementia and aging, volume II.
42. Editorial: Current advances in genetic dementia and aging.
43. Editorial: COVID-19 in CNS and PNS: Basic and Clinical Focus on the Mechanisms of Infection and New Tools for the Therapeutic Approach.
44. Biocompatibility of ferulic/succinic acid-grafted chitosan hydrogels for implantation after brain injury: A preliminary study.
45. Is the brain a reservoir organ for SARS-CoV2?
46. SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases.
47. Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System.
48. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
49. Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation.
50. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.